Antares Pharma, Inc.
ATRSDelisted May 24, 2022- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001016169
Antares Pharma, Inc. was delisted on May 24, 2022; its insiders filed their last Form 4 on May 26, 2022; 177 institutions reported holding it in 13F filings for Q1 2022, worth $374.8M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Antares Pharma, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 163 | 2 | 177 | +16 |
| Shares | 85.6M | 1.85K | 91.5M | +5.94M (+6.9%) |
| Value | $305.5M | $7.00K | $374.8M | +$69.2M (+22.7%) |
2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (26)
Institutions that held Antares Pharma, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (10)
Institutions that held Antares Pharma, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Cornercap Investment Counsel Inc | 138,771 | $495.0K |
| Alps Advisors Inc | 102,178 | $365.0K |
| Zebra Capital Management LLC | 61,984 | $222.0K |
| Spouting Rock Asset Management, LLC | 56,289 | $201.0K |
| Allianz Asset Management GmbH | 16,684 | $60.0K |
| Mercer Global Advisors Inc | 12,963 | $46.0K |
| Capital Advantage, Inc. | 13,000 | $45.0K |
| Elmwood Wealth Management, Inc. | 5,000 | $18.0K |
| Trust Co of Vermont | 1,000 | $4.00K |
| Massmutual Trust Co FSB | 194 | $1.00K |
Not filed for Q1 2022 yet (2)
Institutions that held Antares Pharma, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Reilly Financial Advisors, LLC | 1,000 | $4.00K |
| NEXT Financial Group, Inc | 851 | $3.00K |